mefenamic acid has been researched along with Metrorrhagia in 2 studies
Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
Metrorrhagia: Abnormal uterine bleeding that is not related to MENSTRUATION, usually in females without regular MENSTRUAL CYCLE. The irregular and unpredictable bleeding usually comes from a dysfunctional ENDOMETRIUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The median number of bleeding or spotting days experienced during treatment was 25, 29, and 33 days in the three groups, respectively." | 2.78 | Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial. ( Draeby, J; Inki, P; O'Flynn, M; Schmelter, T; Sørdal, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soper, DE | 1 |
| Sørdal, T | 1 |
| Inki, P | 1 |
| Draeby, J | 1 |
| O'Flynn, M | 1 |
| Schmelter, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| International, Prospective, Double-blind, 3-arm Comparative, Randomized, Placebo-controlled Phase IV Study on the Effect of Counseling and Either Tranexamic Acid or Mefenamic Acid or Placebo, on the Management of Bleeding/Spotting in Women Using the Levon[NCT01295294] | Phase 4 | 187 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for mefenamic acid and Metrorrhagia
| Article | Year |
|---|---|
Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Contraceptive Agents, Femal | 2013 |
1 other study available for mefenamic acid and Metrorrhagia
| Article | Year |
|---|---|
The intrauterine device: a good thing revisited.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Antineoplastic Agents, Hormonal; B | 2013 |